News

From July 1, 2025, international cosmetic manufacturers must comply with five new testing methods in China under updated NMPA regulations.

Effective July 1, 2025, China’s NMPA will implement new GMP annexes for pharmaceutical excipients and packaging materials. Learn about compliance requirements and key timelines for international manufacturers.

Stay ahead of China’s 2025 automotive certification updates. Learn about CCC compliance, GB standards changes, and CCAP regulations affecting car parts.

The NMPA's new biological product registration guidelines take effect on March 10, 2025. Learn about updated submission requirements, compliance rules, and approval pathways for international manufacturers.

China’s oral healthcare market is expanding at a 12% annual rate, with dental anesthesia devices exceeding 1.8 billion yuan. Learn about clinical trends, regulatory requirements, and opportunities for international manufacturers.

China's NMPA introduced new statistical guidelines for vaccine clinical trials in December 2024. Learn how these changes impact trial design, data analysis, and regulatory compliance.

Starting March 1, 2025, EV power supply equipment in China must comply with the CCC certification. Businesses must meet safety standards before the August 1, 2026 deadline.

On March 10, 2025, the NMPA implemented new guidelines for chemical drug registration in China. Learn about stricter electronic submissions, compliance requirements, and their impact on international pharmaceutical companies.

China will enforce new safety standards for household electrical appliances starting August 1, 2026. Learn how GB/T 4706.1—2024 impacts manufacturers, importers, and compliance requirements.

Stay compliant with China’s latest regulations on pet disease antigen screening. Learn how MARA classifies veterinary diagnostic products and what it means for businesses.

China’s NMPA approved 13,133 medical device registrations in 2024, including innovative and priority-reviewed products. Learn about regulatory updates, compliance requirements, and market access opportunities for foreign manufacturers.

Learn about China's latest regulatory updates on nucleic acid testing reagents, market growth trends, and compliance requirements for manufacturers in 2025.

Learn about the latest NMPA regulatory developments affecting medical device compliance in 2024. Understand key inspection findings, risk areas, and compliance strategies for manufacturers.

Discover the latest 2025 medical device standards announced by the NMPA, including mandatory updates and compliance requirements for market access and ISO alignment.

China’s NMPA has released updated inspection principles for medical device clinical trials, effective May 1, 2025. Discover key changes, risk categories, and compliance strategies.

The China Certification Centre for Automotive Products (CCAP) has extended certification validity for select automotive products from 5 to 10 years, effective December 31, 2024. Learn how this impacts manufacturers and compliance processes.

China’s 2025 Action Plan signals wider market access and policy support for foreign enterprises, including medical device manufacturers.

CNCA issued Announcement No. 28 of 2024, releasing updated Implementation Rules for Mandatory Product Certification: Motor Vehicle Tires...

Document No. 53, outlining comprehensive reforms aimed at strengthening the regulation of pharmaceuticals and medical devices. These reforms..

China Medical Device QMS Self-assessment Annual Report must be submitted by March 31, 2025, to avoid sales suspension, fines, and certifica...